2024-11-30 06:01:32
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers
Health/ 2023-07-22
Zhongze Therapeutics Announces Successfu...

SHANGHAI,April 1,2022-- Zhongze Therapeutics,a clinical stage biotech company focused on the discovery,development and commercialization of ...

REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA® ATRIAL SHUNT
Health/ 2023-07-22
REDUCE LAP-HF II ANALYSES SHOW 50% OF ST...

Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy TEWKSBURY,Mass.,April 1,2022-- Corvia Me...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release